Results 181 to 190 of about 1,122,477 (316)
Advancing preclinical drug evaluation through automated 3D imaging for high-throughput screening with kidney organoids. [PDF]
BiofabricationOishi H, Tabibzadeh N, Morizane R.
europepmc +1 more source
COVID-19 emergency responders in FDA's Center for Drug Evaluation and Research. [PDF]
J Am Pharm Assoc (2003), 2020 Gormley LCA, Ngan CK.
europepmc +1 more source
Evaluation of drug-induced changes in myocardial repolarisation using the paced evoked response. [PDF]
, 1982 Robert M. Donaldson, A F Rickards
openalex +1 more source
Molecular Oncology, EarlyView.Inhibition of protein SUMOylation has been shown to block tumorigenesis; however, the specific mechanisms by which SUMOylation controls the tumor‐initiating capacities remain elusive. Li et al. describe the role of Etv1 SUMOylation in cancer stem cells using mouse models of mammary gland tumorigenesis.
Veronika Yevdokimova, Yannick D. Benoit
wiley +1 more source
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here? [PDF]
HepatologyJones DEJ +24 more
europepmc +1 more source
Suitability of external controls for drug evaluation in Duchenne muscular dystrophy. [PDF]
Neurology, 2020 Goemans N +13 more
europepmc +1 more source
Molecular Oncology, EarlyView.In prostate carcinoma, lactic acid, secreted by highly glycolytic cancer‐associated fibroblasts, is imported into tumor cells through the MCT1 transporter and prevents RSL3 and erastin‐induced ferroptosis (A). Targeting of carbonic anhydrase IX/XII, the main extracellular pH regulators, in tumor and stromal cells reduces microenvironmental acidosis and
Elisa Pardella +18 more
wiley +1 more source
Studies on Methods for Evaluation of Anticoccidial Drugs in Vitro
, 1974 Keizaburo ITAGAKI +2 more
openalex +2 more sources
Evaluation of Drug-Drug Interactions in Drug Development.
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 2003 Dipti M. Amin, Jean-Pierre Isal
openaire +3 more sources